Dimerix Limited DXB.AX · Stock Open Dimerix Limited in new tab
Dimerix Limited Analysis (DXB.AX)
Is Dimerix Limited a good investment? Dimerix Limited (DXB.AX) is currently trading at 0.2400 AUD.
Earnings Schedule: Dimerix Limited is expected to release its next earnings report on Sept. 2, 2026. The market consensus estimate for Forward EPS is -0.02.
Investor FAQ
Does Dimerix Limited pay a dividend?
No, it does not currently pay a dividend.
What asset class is Dimerix Limited?
Dimerix Limited is classified as a Stock. You can compare it against its peer in the "Related Symbols" list.
When is the next earnings date?
The next earnings date is projected to be Sept. 2, 2026. The company currently has a trailing EPS of -0.03.
Company Profile
Dimerix Limited, a biopharmaceutical company, develops and commercializes pharmaceutical products for unmet medical needs in Australia. It develops DMX-200 for the treatment of focal segmental glomerulosclerosis disease, diabetic kidney disease, and ARDS associated with COVID-19; and DMX-700 for orphan respiratory/renal disease, as well as proprietary Receptor-HIT assay technology. The company is headquartered in Fitzroy, Australia.
| Year | Total Dividends |
|---|---|
| ▸1999 |
1.22 AUD
|
| May 21, 1999 | 0.0017 |
| May 21, 1999 | 1.2151 |
| ▸1998 |
6.81 AUD
|
| Sept. 18, 1998 | 0.0097 |
| Sept. 18, 1998 | 6.8048 |
| Split Date | Split Ratio to 1 |
|---|---|
| Jan. 24, 2005 | 0.400000 |
| Oct. 4, 2012 | 0.071429 |
| Oct. 23, 2017 | 0.050000 |
| Oct. 4, 2012 | 0.070000 |
| July 3, 1992 | 5.000000 |
Community Discussion